Transdermal Drug Delivery Systems Market - Company Profile (Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Acrux Limited, Echo Therapeutics, Inc., and Endo Pharmaceuticals Inc.)and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILES

1.1. ACRUX LIMITED

1.1.1. Company overview

1.1.2. Company snapshot

1.1.3. Operating business segments

1.1.4. Business performance

1.1.5. Key strategic moves and developments

1.1.6. Strategy share (%)

1.2. BAYER AG

1.2.1. Company overview

1.2.2. Company snapshot

1.2.3. Operating business segments

1.2.4. Business performance

1.2.5. Key strategic moves and developments

1.2.6. Strategy share (%)

1.3. BOEHRINGER INGELHEIM GMBH

1.3.1. Company overview

1.3.2. Company snapshot

1.3.3. Operating business segments

1.3.4. Business performance

1.3.5. Key strategic moves and developments

1.3.6. Strategy share (%)

1.4. BRISTOL-MYERS SQUIBB COMPANY

1.4.1. Company overview

1.4.2. Company snapshot

1.4.3. Operating business segments

1.4.4. Business performance

1.4.5. Key strategic moves and developments

1.4.6. Strategy share (%)

1.5. ECHO THERAPEUTICS, INC.

1.5.1. Company overview

1.5.2. Company snapshot

1.5.3. Operating business segments

1.5.4. Business performance

1.5.5. Key strategic moves and developments

1.5.6. Strategy share (%)

1.6. ENDO PHARMACEUTICALS INC.

1.6.1. Company overview

1.6.2. Company snapshot

1.6.3. Operating business segments

1.6.4. Business performance

1.6.5. Key strategic moves and developments

1.6.6. Strategy share (%)

1.7. GLAXOSMITHKLINE PLC

1.7.1. Company overview

1.7.2. Company snapshot

1.7.3. Operating business segments

1.7.4. Business performance

1.7.5. Key strategic moves and developments

1.7.6. Strategy share (%)

1.8. JOHNSON & JOHNSON

1.8.1. Company overview

1.8.2. Company snapshot

1.8.3. Operating business segments

1.8.4. Business performance

1.8.5. Key strategic moves and developments

1.8.6. Strategy share (%)

1.9. MYLAN N.V.

1.9.1. Company overview

1.9.2. Company snapshot

1.9.3. Operating business segments

1.9.4. Business performance

1.9.5. Key strategic moves and developments

1.9.6. Strategy share (%)

1.10. NOVARTIS AG

1.10.1. Company overview

1.10.2. Company snapshot

1.10.3. Operating business segments

1.10.4. Business performance

1.10.5. Key strategic moves and developments

1.10.6. Strategy share (%)

LIST OF TABLES AND FIGURES

TABLE 1. ACRUX: COMPANY SNAPSHOT

TABLE 2. ACRUX: OPERATING SEGMENTS

TABLE 3. BAYER: COMPANY SNAPSHOT

TABLE 4. BAYER: OPERATING SEGMENTS

TABLE 5. BOEHRINGER: COMPANY SNAPSHOT

TABLE 6. BOEHRINGER: OPERATING SEGMENTS

TABLE 7. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT

TABLE 8. BRISTOL-MYERS SQUIBB: OPERATING SEGMENTS

TABLE 9. ECHO: COMPANY SNAPSHOT

TABLE 10. ECHO: OPERATING SEGMENTS

TABLE 11. ENDO: COMPANY SNAPSHOT

TABLE 12. ENDO: OPERATING SEGMENTS

TABLE 13. GSK: COMPANY SNAPSHOT

TABLE 14. GSK: OPERATING SEGMENTS

TABLE 15. J&J: COMPANY SNAPSHOT

TABLE 16. J&J: OPERATING SEGMENTS

TABLE 17. MYLAN: COMPANY SNAPSHOT

TABLE 18. MYLAN: OPERATING SEGMENTS

TABLE 19. NOVARTIS: COMPANY SNAPSHOT

TABLE 20. NOVARTIS: OPERATING SEGMENTS